Translate Bio Inc.

(TBIO) Trade

Symbol has changed to a new ticker symbol

(TBIOD)

By |

Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Contact Information

Website: www.translate.bio
Email: tdahlman@translate.bio
Main Phone: +1 617 945-7361
Address: 29 Hartwell Avenue
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Ronald C. Renaud
Employees: 93
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Contact Information

Website: www.translate.bio
Email: tdahlman@translate.bio
Main Phone: +1 617 945-7361
Address: 29 Hartwell Avenue
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Ronald C. Renaud
Employees: 93
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 14.75 $ 0.46 (3.22%)
Last Price 14.75 Change $ 0.46 Change % 3.22 Tick N/A
Bid 14.81 Bid Size 100.00 Ask 15.00 Ask Size 100.00
Open 14.18 High 14.77 Low 13.87 Prev Close 14.29
Last Trade Volume 786,858 52 Wk Hi 28.10 52 Wk Low 6.81
Market Cap 1.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 74,243,943.00 EPS (TTM) -1.74 PE Ratio N/A Exchange NGS